Pharmaceuticals

VIGONVITA-B

Wangshan Wangshui Reports First Profit Report with Successful Commercialization of ED New Drug

Wangshan Wangshui-B Reports 2025 Earnings: Revenue Up 762.9% Y-o-Y and Gross Profit Soars by 2,213.7%

VIGONVITA-B released FY2025 Annual Earnings on March 31, 2026 (BJT) with actual revenue of HKD 111.59 M and EPS of HKD -2.5465

VIGONVITA-B to Release FY2025 Earnings Report on March 31, 2026 (BJT)

VIGONVITA-B released FY2023 earnings on October 27, 2025 (BJT) with actual revenue of HKD 219.25 M and EPS of HKD 0.0918

VIGONVITA-B released FY2024 earnings on October 27, 2025 (BJT) with actual revenue of HKD 12.81 M and EPS of HKD -1.5721

CH DEMETER FIN

FAMEGLOW

LUEN THAI

NEW GONOW RV

REF HOLDINGS

PARADISE ENT

WEBX HOLDING

HAICHANG HLDG

BEST FOOD HLDG

INTELLIMARK W27

06090

02632

01066

01126

03887

01798

01440

02650

02630

02729

BUTONG GROUP(06090) fell 21.1%, with a trading turnover 43.6 Million HKD, and a year-to-date fell 49%. NEW VISION CO(02632) fell 18.97%, with a trading turnover 20.5 Million HKD, and a year-to-date rose 6.3%. WEIGAO GROUP(01066) fell 17.47%, with a trading turnover 367.4 Million HKD, and a year-to-date fell 24.7%.

Top Gainers&Losers

BUTONG GROUP

NEW VISION CO

WEIGAO GROUP

DREAM INT'L

HASHKEY HLDGS

DATANG RENEW

STAR SHINE HLDG

ZHIDA TECH

GALAXIS TECH

Top 10 HK Stock Losers (3.30)

02155

06683

00568

03355

07489

02715

02419

02643

02701

VIGONVITA-B(02630) fell 17.06%, with a trading turnover 44.6 Million HKD, and a year-to-date rose 7.5%. MORIMATSU INTL(02155) fell 14.04%, with a trading turnover 439.4 Million HKD, and a year-to-date fell 29.6%. STARPLUS LEGEND(06683) fell 11.06%, with a trading turnover 871.2 Million HKD, and a year-to-date rose 30.4%.

MORIMATSU INTL

STARPLUS LEGEND

SHANDONG MOLONG

FS.COM

VOYAH AUTO

ESTUN

DEKON AGR

CAOCAO INC

NSING TECH

Top 10 HK Stock Losers (3.24)

06693

03788

02575

01989

03330

02627

09690

02598

02706

CHIFENG GOLD(06693) fell 25.1%, with a trading turnover 1.4 Billion HKD, and a year-to-date rose 5.9%. VIGONVITA-B(02630) fell 15.79%, with a trading turnover 8.4 Million HKD, and a year-to-date rose 29.6%. HANKING GOLD(03788) fell 13.57%, with a trading turnover 54.0 Million HKD, and a year-to-date fell 4.7%.

CHIFENG GOLD

HANKING GOLD

XUANZHUBIO-B

DELTON

LINGBAO GOLD

AB&B BIO-TECH-B

TUHU-W

LIANLIAN

HAIZHI TECH GP

Top 10 HK Stock Losers (3.23)

08427

08283

The Hong Kong stock market has shown a clear divergence in the past hour, with some stocks performing strongly while others faced significant declines. In particular, small-cap stocks and gold-related stocks exhibited large fluctuations, as funds seem to be searching for short-term hotspots. The strong rise of WS-SK TARGET attracted considerable capital inflow, while stocks like ZHONGSHI MINAN faced selling pressure due to weakening market sentiment, resulting in a generally fast-paced rhythm and noticeable short-term heat. The stock with the largest movement in the past hour, WS-SK TARGET, surged 21.17%, drawing strong attention in the market, with rapid capital inflow and heightened short-term sentiment, indicating potential for further upward movement. In contrast, ZHONGSHI MINAN saw a decline of 19.18%, reflecting market concerns about its prospects and evident selling pressure. 

Strong stocks:
1. TIANLI HOLDINGS: up 16.05%, with significant recent capital inflow and optimistic market sentiment.
2. BRIGHT SMART: up 12.70%, performing outstandingly in the financial sector and attracting considerable short-term funds.
3. ZHONGAN SERVICE: up 11.32%, seemingly benefiting from market preference for tech stocks, with increased activity.

Stocks under pressure:
1. LINGBAO GOLD: down 16.71%, pressured by market concerns over gold prices, with evident capital outflow.
2. VIGONVITA-B: down 16.51%, lacking support in the short term, leading to low investor sentiment.
3. GT GOLD: down 15.79%, performing poorly against the backdrop of an overall decline in the gold sector

HK Stock Alerts

WS-SK TARGET

ZHONGSHI MINAN

TIANLI HOLDINGS

GT GOLD

BRIGHT SMART

ZHONGAN SERVICE

WANGUO GOLD GP

Hong Kong Stock Market Movement Update: The Hong Kong stock market shows significant fluctuations, with WS-SK TARGET soaring 21.17% and ZHONGSHI MINAN dropping 19.18%

159506

516930

520880

Vigonvita Shareholders Unanimously Approve New H Share Award Scheme

Tip Ranks

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

Minsheng Royal CSI Biotechnology Theme ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

China Merchants CSI Biotechnology Theme ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

ChinaAMC SSE Health Care ETF Initiating Fund

Guotai CSI Bio-medicine ETF

Yinhua CSI Innovative Drugs Industry ETF

ChinaAMC CSI Biotechnology Theme ETF

E Fund CSI 300 Health Care ETF

E Fund Hang Seng SCHK Innovative Drug ETF

Penghua CSI HK Connect Health Care Composite ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

E Fund CSI Biotechnology Theme ETF

ChinaAMC SSE STAR Biology and Medicine ETF

Bosera Hang Seng Health Care ETF(QDII)

Vigonvita Shareholders Unanimously Approve New H Share Award Scheme

06608

02659

01857

02427

00400

00658

06166

03986

BAIRONG-W(06608) fell 18.78%, with a trading turnover 115.5 Million HKD, and a year-to-date fell 17.2%. BAO PHARMA-B(02659) fell 14.89%, with a trading turnover 67.0 Million HKD, and a year-to-date rose 99.7%. CEB WATER(01857) fell 12.5%, with a trading turnover 20.2 Million HKD, and a year-to-date fell 3.9%.

BAIRONG-W

BAO PHARMA-B

CEB WATER

GUANZE MEDICAL

INGDAN

C TRANSMISSION

GIGADEVICE

Top 10 HK Stock Losers (2.27)

00100

00290

06809

00826

02587

03738

HAIZHI TECH GP(02706) rose 29.59%, with a trading turnover 685.0 Million HKD, and a year-to-date rose 343.5%. MINIMAX-WP(00100) rose 24.56%, with a trading turnover 1.9 Billion HKD, and a year-to-date rose 413.3%. GOFINTECH QUANT(00290) rose 21.15%, with a trading turnover 38.2 Million HKD, and a year-to-date rose 18%.

MINIMAX-W

GOFINTECH QUANT

MONTAGE TECH

TIANGONG INT'L

HEALTHYWAY INC

VOBILE GROUP

Top 10 HK Stock Gainers (2.16)

01877

688180

A domestically produced COVID-19 drug VV116 has been confirmed to have significant antiviral activity against the Nipah virus, which has a mortality rate of up to 70%. Animal experiments show that it can increase the survival rate of infected golden hamsters to 66.7%. However, the responses from the partner Junshi Biosciences-U and VIGONVITA-B were inconsistent; the former did not conduct related research, while the latter plans to initiate clinical trials. Affected by this news, VIGONVITA-B's stock price rose nearly 15%, and Junshi Biosciences-U also increased by 7.96%

- A domestically launched COVID-19 oral drug, VV116, shows significant antiviral activity against the highly lethal Nipah virus, which has no approved treatment.  
- Research published by the Wuhan Institute of Virology indicates that VV116 can increase survival rates in infected animal models while reducing viral loads in key organs.  
- Despite this promising result, the domestic development partners provided differing responses regarding further clinical trials, reflecting potential challenges in the drug's application against Nipah virus.

Wallstreetcn

JUNSHI BIO

Junshi Biosciences

Is the high mortality rate Nipah virus facing its nemesis? The domestic COVID-19 drug VV116 shows effectiveness across fields, and the two partners respond to the current "temperature difference."

02473

09860

02669

02097

06666

02442

09636

00108

02179

XXF(02473) fell 14.46%, with a trading turnover 286.1 Million HKD, and a year-to-date rose 48.1%. ADICON HOLDINGS(09860) fell 12.03%, with a trading turnover 105.9 Million HKD, and a year-to-date rose 22.7%. CHINA OVS PPT(02669) fell 11.93%, with a trading turnover 528.1 Million HKD, and a year-to-date fell 5.3%.

VIGONVITA-B(02630.HK)

Top 10 HK Stock Losers (3.30)

Top 10 HK Stock Losers (3.24)

Top 10 HK Stock Losers (3.23)

Hong Kong Stock Market Movement Update: The Hong Kong stock market shows significant fluctuations, with WS-SK TARGET soaring 21.17% and ZHONGSHI MINAN dropping 19.18%

Vigonvita Shareholders Unanimously Approve New H Share Award Scheme

Top 10 HK Stock Losers (2.27)

Top 10 HK Stock Gainers (2.16)

Is the high mortality rate Nipah virus facing its nemesis? The domestic COVID-19 drug VV116 shows effectiveness across fields, and the two partners respond to the current "temperature difference."

Top 10 HK Stock Losers (1.28)